{"id":"https://openalex.org/W4391968218","doi":"https://doi.org/10.1177/13524585241227372","title":"A US payer perspective health economic model assessing value of monitoring disease activity to inform discontinuation and re-initiation of DMT in multiple sclerosis","display_name":"A US payer perspective health economic model assessing value of monitoring disease activity to inform discontinuation and re-initiation of DMT in multiple sclerosis","publication_year":2024,"publication_date":"2024-02-19","ids":{"openalex":"https://openalex.org/W4391968218","doi":"https://doi.org/10.1177/13524585241227372","pmid":"https://pubmed.ncbi.nlm.nih.gov/38374525"},"language":"en","primary_location":{"id":"doi:10.1177/13524585241227372","doi":"https://doi.org/10.1177/13524585241227372","is_oa":true,"landing_page_url":"https://doi.org/10.1177/13524585241227372","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/13524585241227372?download=true","source":{"id":"https://openalex.org/S136332993","display_name":"Multiple Sclerosis Journal","issn_l":"1352-4585","issn":["1352-4585","1477-0970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://journals.sagepub.com/doi/pdf/10.1177/13524585241227372?download=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047639059","display_name":"Kian Jalaleddini","orcid":"https://orcid.org/0000-0002-1545-158X","observed_orcids":["https://orcid.org/0000-0002-1545-158X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Kian Jalaleddini","raw_affiliation_strings":["Octave Bioscience Inc., Menlo Park, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Octave Bioscience Inc., Menlo Park, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109838419","display_name":"Robert A. Bermel","orcid":"https://orcid.org/0000-0003-2334-6883","observed_orcids":["https://orcid.org/0000-0003-2334-6883"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A Bermel","raw_affiliation_strings":["Mellen Center for Multiple Sclerosis, Department of Neurology, Cleveland Clinic, Cleveland, OH, USA"],"raw_orcid":"https://orcid.org/0000-0003-2334-6883","affiliations":[{"raw_affiliation_string":"Mellen Center for Multiple Sclerosis, Department of Neurology, Cleveland Clinic, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079684116","display_name":"Bari Talente","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334995288","display_name":"National Multiple Sclerosis Society","ror":"https://ror.org/03019wv17","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1334995288"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bari Talente","raw_affiliation_strings":["National MS Society, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National MS Society, New York, NY, USA","institution_ids":["https://openalex.org/I1334995288"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David Weinstein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Weinstein","raw_affiliation_strings":["Extropy Health Solutions, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Extropy Health Solutions, Tucson, AZ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072497750","display_name":"Ferhan Qureshi","orcid":"https://orcid.org/0000-0002-5158-0485","observed_orcids":["https://orcid.org/0000-0002-5158-0485"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ferhan Qureshi","raw_affiliation_strings":["Octave Bioscience Inc., Menlo Park, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Octave Bioscience Inc., Menlo Park, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111132480","display_name":"Maital Rasmussen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maital Rasmussen","raw_affiliation_strings":["Octave Bioscience Inc., Menlo Park, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Octave Bioscience Inc., Menlo Park, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079139415","display_name":"Sreeranjani Menon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sreeranjani Menon","raw_affiliation_strings":["Boston Healthcare Associates, Inc. (now a Veranex company), Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston Healthcare Associates, Inc. (now a Veranex company), Boston, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090507715","display_name":"Miyuru Amarapala","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Miyuru Amarapala","raw_affiliation_strings":["Boston Healthcare Associates, Inc. (now a Veranex company), Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston Healthcare Associates, Inc. (now a Veranex company), Boston, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033939519","display_name":"Kesshi Jordan","orcid":"https://orcid.org/0000-0001-6313-0580","observed_orcids":["https://orcid.org/0000-0001-6313-0580"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kesshi Jordan","raw_affiliation_strings":["Octave Bioscience Inc., Menlo Park, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Octave Bioscience Inc., Menlo Park, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084049314","display_name":"Ati Ghoreyshi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ati Ghoreyshi","raw_affiliation_strings":["Octave Bioscience Inc., Menlo Park, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Octave Bioscience Inc., Menlo Park, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Shannon McCurdy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shannon McCurdy","raw_affiliation_strings":["Octave Bioscience Inc., Menlo Park, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Octave Bioscience Inc., Menlo Park, CA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5093963494","display_name":"Mike Edgeworth","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mike Edgeworth","raw_affiliation_strings":["Octave Bioscience Inc., Menlo Park, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Octave Bioscience Inc., Menlo Park, CA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5047639059"],"corresponding_institution_ids":[],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":0.9121,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.71421791,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"30","issue":"3","first_page":"432","last_page":"442"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9678000211715698,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9678000211715698,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.03060000017285347,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T14138","display_name":"Life Cycle Costing Analysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1402","display_name":"Accounting"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.8859999775886536},{"id":"https://openalex.org/keywords/relapsing-remitting-multiple-sclerosis","display_name":"relapsing-remitting multiple sclerosis","score":0.925000011920929},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.9390000104904175},{"id":"https://openalex.org/keywords/immunosenescence","display_name":"immunosenescence","score":0.8830000162124634},{"id":"https://openalex.org/keywords/disease-activity-monitoring","display_name":"disease activity monitoring","score":0.921999990940094},{"id":"https://openalex.org/keywords/risk-of-relapse","display_name":"relapse risk","score":0.7020000219345093},{"id":"https://openalex.org/keywords/edss-progression","display_name":"EDSS progression","score":0.7229999899864197},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.6660000085830688},{"id":"https://openalex.org/keywords/payer-perspective","display_name":"payer perspective","score":0.7919999957084656},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.5929999947547913}],"concepts":[{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.9355714321136475},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8467960357666016},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.6951218247413635},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5320720672607422},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5219683051109314},{"id":"https://openalex.org/C524218345","wikidata":"https://www.wikidata.org/wiki/Q31218","display_name":"Health economics","level":3,"score":0.4293712079524994},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4202066659927368},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3996468782424927},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3561387062072754},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3559685945510864},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.33543992042541504},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.19025444984436035},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.13040819764137268},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08521595597267151}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018803","descriptor_name":"Models, Economic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018803","descriptor_name":"Models, Economic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018803","descriptor_name":"Models, Economic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/13524585241227372","doi":"https://doi.org/10.1177/13524585241227372","is_oa":true,"landing_page_url":"https://doi.org/10.1177/13524585241227372","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/13524585241227372?download=true","source":{"id":"https://openalex.org/S136332993","display_name":"Multiple Sclerosis Journal","issn_l":"1352-4585","issn":["1352-4585","1477-0970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis Journal","raw_type":"journal-article"},{"id":"pmid:38374525","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38374525","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple sclerosis (Houndmills, Basingstoke, England)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1177/13524585241227372","doi":"https://doi.org/10.1177/13524585241227372","is_oa":true,"landing_page_url":"https://doi.org/10.1177/13524585241227372","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/13524585241227372?download=true","source":{"id":"https://openalex.org/S136332993","display_name":"Multiple Sclerosis Journal","issn_l":"1352-4585","issn":["1352-4585","1477-0970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis Journal","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/17","score":0.4699999988079071,"display_name":"Partnerships for the goals"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308604","display_name":"Biogen","ror":"https://ror.org/02jqkb192"},{"id":"https://openalex.org/F4320309680","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83"},{"id":"https://openalex.org/F4320313971","display_name":"TG Therapeutics","ror":"https://ror.org/00pwykz63"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320332200","display_name":"EMD Serono","ror":"https://ror.org/027zrs220"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4391968218.pdf","grobid_xml":"https://content.openalex.org/works/W4391968218.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W37353277","https://openalex.org/W1978103330","https://openalex.org/W2067673653","https://openalex.org/W2146236437","https://openalex.org/W2767362256","https://openalex.org/W2937465963","https://openalex.org/W2964503338","https://openalex.org/W2981168806","https://openalex.org/W3004739468","https://openalex.org/W3012517977","https://openalex.org/W3025379451","https://openalex.org/W3048359327","https://openalex.org/W3097683738","https://openalex.org/W3131957723","https://openalex.org/W3178657798","https://openalex.org/W3183672670","https://openalex.org/W3193418223","https://openalex.org/W4205377301","https://openalex.org/W4206906083","https://openalex.org/W4206951744","https://openalex.org/W4223910252","https://openalex.org/W4241293427","https://openalex.org/W4241890711","https://openalex.org/W4294576905","https://openalex.org/W4306943620"],"related_works":["https://openalex.org/W2963953516","https://openalex.org/W2533767944","https://openalex.org/W7217838365","https://openalex.org/W4317754423","https://openalex.org/W2791181325","https://openalex.org/W7160432466","https://openalex.org/W4389446080","https://openalex.org/W4394601695","https://openalex.org/W4409234520","https://openalex.org/W4386988771"],"abstract_inverted_index":{"OBJECTIVES:":[0],"We":[1],"evaluate":[2],"the":[3,41,81,130,147,161,182],"potential":[4],"clinical":[5,36,156,172],"and":[6,37,43,72,94,111,173],"cost":[7,38,95,163,174],"impacts":[8,39],"of":[9,48,69,75,83,122,139,149,184],"discontinuing":[10],"disease-modifying":[11],"therapy":[12,89],"(DMT)":[13],"in":[14,103,129,143],"people":[15],"with":[16,51],"multiple":[17,54],"sclerosis":[18,55],"(PwMS)":[19],"when":[20,45],"age-related":[21],"immunosenescence":[22],"can":[23,186],"reduce":[24],"DMT":[25,154,196],"efficacy":[26],"while":[27,160],"increasing":[28],"associated":[29],"risks.":[30],"METHODS:":[31],"A":[32],"Markov":[33],"model":[34],"simulated":[35],"to":[40,87,152,193],"patient":[42,165],"payers":[44],"a":[46,136],"proportion":[47,82,138,148],"eligible":[49,84,107,178],"patients":[50,85,108,150,179],"relapsing":[52],"remitting":[53],"(RRMS)":[56],"discontinue":[57,88,153],"DMT.":[58],"Eligibility":[59],"was":[60,90,116],"defined":[61],"as":[62,176],"age":[63],">55":[64],"years,":[65,71],"an":[66],"RRMS":[67],"diagnosis":[68],">5":[70],"no":[73],"history":[74],"relapses":[76,140,185],"for":[77],"5":[78],"years.":[79],"Increasing":[80],"willing":[86,151],"also":[91],"modeled.":[92],"Clinical":[93],"inputs":[96],"were":[97,126,141],"from":[98],"published":[99],"literature.":[100],"RESULTS:":[101],"Difference":[102],"EDSS":[104],"progression":[105],"between":[106],"who":[109],"did":[110,112],"not":[113,117],"attempt":[114,180],"discontinuation":[115],"significant.":[118],"After":[119],"1":[120],"year":[121],"eligibility,":[123],"per-patient":[124],"costs":[125],"$96k":[127],"lower":[128],"cohort":[131],"that":[132],"attempted":[133],"discontinuation;":[134],"however":[135],"higher":[137],"seen":[142],"this":[144],"group.":[145],"When":[146],"increased,":[155],"findings":[157],"remained":[158],"consistent":[159],"average":[162],"per":[164],"decreased.":[166],"CONCLUSION:":[167],"While":[168],"there":[169],"are":[170],"increased":[171],"benefits":[175],"more":[177],"discontinuation,":[181],"risk":[183],"increase.":[187],"Timely":[188],"disease":[189],"monitoring":[190],"is":[191],"required":[192],"manage":[194],"safe":[195],"discontinuation.":[197]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2024-02-21T00:00:00"}